Attorneys See Uncertainty in FDA's Implementation of Biosimilar Approvals, Life Sciences Law & Industry Report

by: Life Sciences Law & Industry Report

• date: 05/28/2010
• news source: Life Sciences Law & Industry Report

Morgan Lewis partner Kathleen Sanzo discusses the use of traditional biologics license application (BLA) versus the new biosimilars pathway provided for in the healthcare reform law at the May 20 Washington Legal Foundation media briefing.

Read the article on Life Sciences Law & Industry's website.

Related Attorneys:
Kathleen M. Sanzo